1. Bevacizumab in advanced breast cancer: an opportunity as second-line therapy?

   • Fausto Petrelli
   • Sandro Barni

   Original Paper 14 December 2010 Pages: 1 - 4

   

2. Correlation of major histocompatibility complex class I related A (MICA) polymorphism with the risk of developing breast cancer

   • Sadeq Vallian
   • Morteza Javadi Rad
   • Manoochehr Tavassoli

   Original Paper 08 January 2011 Pages: 5 - 9

3. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells

   • Jing-song Wang
   • Tian-nian Ren
   • Tao Xi

   Original Paper 30 December 2010 Pages: 10 - 15

   

4. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience

   • Robert Díaz
   • Blanca Munárriz
   • Joaquín Montalar

   Original Paper 31 December 2010 Pages: 16 - 24

   

5. Role of Na⁺/H⁺ exchanger in resveratrol-induced growth inhibition of human breast cancer cells

   • Heba Mehdawi
   • Moussa Alkhalaf
   • Islam Khan

   Original Paper 30 December 2010 Pages: 25 - 32

   

6. Safety and efficacy of gemcitabine plus cisplatin combination in pretreated metastatic breast cancer patients

   • Luiz Gustavo Oliveira Brito
   • Jurandyr Moreira de Andrade
   • Fernanda Maris Peria

   Original Paper 25 January 2011 Pages: 33 - 38

   

7. Comparison of overall survival between the early use and delayed use of Trastuzumab therapy groups: a retrospective analysis of 128 patients with HER-2-positive advanced breast cancer

   • Yan-Xia Shi
   • Yu-Ting Tan
   • Dong-Geng Liu

   Original Paper 08 February 2011 Pages: 39 - 47

   

8. The role of human papillomavirus infection in breast cancer

   • Ting Wang
   • Peng Chang
   • Christopher Cao

   Review Article 13 February 2011 Pages: 48 - 55

   

9. Gemcitabine and cisplatin combination regimen in patients with anthracycline- and taxane-pretreated metastatic breast cancer

   • Tao Wang
   • Shaohua Zhang
   • Zefei Jiang

   Original Paper 25 January 2011 Pages: 56 - 61

   

10. Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft

    • Zhi-kui Chen
    • Min-xian Cai
    • Li-ming Ke

    Original paper 07 December 2010 Pages: 62 - 69

    

11. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells

    • Weilin Wang
    • Jianju Lu
    • Shusen Zheng

    Original paper 29 December 2010 Pages: 70 - 76

    

12. Upregulated INHBA expression is associated with poor survival in gastric cancer

    • Quan Wang
    • Yu-Gang Wen
    • Zhi-Hai Peng

    Original Paper 04 December 2010 Pages: 77 - 83

    

13. Altered mRNA expressions of sialyltransferases in human gastric cancer tissues

    • Li Jun
    • Wang Yuanshu
    • Cui Shuxiang

    Original Paper 08 December 2010 Pages: 84 - 90

    

14. Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells

    • Dawei Ju
    • Dazhi Sun
    • Pinkang Wei

    Original paper 30 December 2010 Pages: 91 - 99

    

15. Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy

    • ShengLi He
    • Jie Shen
    • DaoYong Niu

    Original Paper 25 January 2011 Pages: 100 - 106

    

16. Quantitative analysis of promoter methylation of the EDNRB gene in gastric cancer

    • Kaixiong Tao
    • Chuanqing Wu
    • Guobin Wang

    Original Paper 25 January 2011 Pages: 107 - 112

    

17. CIP2A is overexpressed in esophageal squamous cell carcinoma

    • Wei Qu
    • Wenjuan Li
    • Jinming Yu

    Original Paper 08 December 2010 Pages: 113 - 118

    

18. Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo

    • Ji Ma
    • Jian Zhang
    • Wenchao Liu

    Original Paper 16 December 2010 Pages: 119 - 126

    

19. Gene expression profiling guiding diagnosis and therapy of rare mammary-like anogenital gland carcinomas

    • Peter Gunvén
    • Margareta Randén
    • Arno Floore

    Original Paper 04 December 2010 Pages: 127 - 132

    

20. Significance of microsatellite instability (MSI) for colorectal cancer following adjuvant therapy with doxifluridine

    • Toshiaki Watanabe
    • Keiji Matsuda
    • Hisae Iinuma

    Letter to the Editor 15 January 2011 Pages: 133 - 133

21. Cell membrane and cytoplasmic epidermal growth factor receptor expression in pancreatic ductal adenocarcinoma

    • Amit Mahipal
    • Mary J. Mcdonald
    • Brian I. Carr

    Original Paper 25 January 2011 Pages: 134 - 139

    

22. Long-term recurrence-free survival in a patient with pancreatic carcinosarcoma: A case report with a literature review

    • Wen-Yan Zhu
    • Tai-Guo Liu
    • Hong Zhu

    Original Paper 25 January 2011 Pages: 140 - 143

    

23. Late recurrences of gastrointestinal stromal tumours (GISTs) after 5 years of follow-up

    • Margherita Nannini
    • Guido Biasco
    • Maria Abbondanza Pantaleo

    Original Paper 22 January 2011 Pages: 144 - 150

24. Association of β-catenin, Wnt1, Smad4, Hoxa9, and Bmi-1 with the prognosis of esophageal squamous cell carcinoma

    • Jin Lv
    • Xiu-Feng Cao
    • Su-Qing Li

    Original Paper 23 January 2011 Pages: 151 - 160

    

25. The role of XPD in cell apoptosis and viability and its relationship with p53 and cdk2 in hepatoma cells

    • Hong-yun Wang
    • Gao-fei Xiong
    • Xiang-yang Xiong

    Original Paper 25 January 2011 Pages: 161 - 167

    

26. Prognostic value of Smac expression in rectal cancer patients treated with neoadjuvant therapy

    • Hongjiang Yan
    • Jinming Yu
    • Zhongfa Xu

    Original Paper 25 January 2011 Pages: 168 - 173

    

27. Quantitative proteomic analysis identifying three annexins as lymph node metastasis-related proteins in lung adenocarcinoma

    • Ying-Fu Liu
    • Yong-Heng Chen
    • Zhu-Chu Chen

    Original paper 04 December 2010 Pages: 174 - 184

    

28. Significance of pretreatment comorbidities in elderly patients with advanced non-small-cell lung cancer treated with chemotherapy or epidermal growth factor receptor-tyrosine kinase inhibitor

    • Kaoru Irisa
    • Katsuhiro Masago
    • Michiaki Mishima

    Original Paper 07 December 2010 Pages: 185 - 192

    

29. Erlotinib in patients with advanced non-small-cell lung cancer: impact of dose reductions and a novel surrogate marker

    • Daniel Binder
    • Ann-Christin Buckendahl
    • Norbert Suttorp

    Original Paper 14 December 2010 Pages: 193 - 198

    

30. Irinotecan plus cisplatin chemotherapy followed by concurrent thoracic irradiation with low-dose weekly cisplatin for limited-disease small-cell lung cancer

    • Hanan A. Wahba
    • Amal A. Halim
    • Hend A. El-Hadaad

    Original Paper 08 December 2010 Pages: 199 - 204

    

31. Lung fluorescence imaging to evaluate tumor metastasis induced by AQP5 expression in murine model

    • Zi-qiang Zhang
    • Zhu-xian Zhu
    • Chun-xue Bai

    Original Paper 31 December 2010 Pages: 205 - 211

    

32. Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer

    • Haitam Nasrallah
    • Gil Bar-Sela
    • Nissim Haim

    Original Paper 25 January 2011 Pages: 212 - 214

    

33. Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer

    • Motohiro Tamiya
    • Hidekazu Suzuki
    • Ichiro Kawase

    Original Paper 22 January 2011 Pages: 215 - 218

    

34. BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?

    • Franz X. Gruber
    • Tuija Lundán
    • Henrik Hjorth-Hansen

    Original Paper 08 January 2011 Pages: 219 - 226

    

35. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma

    • Hong-Feng Gou
    • Jian Zang
    • Xin-Chuan Chen

    Original Paper 31 December 2010 Pages: 227 - 234

    

36. The rare-earth yttrium complex [YR(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells

    • Soo-Young Lee
    • Ilja Peckermann
    • Aram Prokop

    Original Paper 30 December 2010 Pages: 235 - 242

    

37. miR-153 sensitized the K562 cells to As2O3-induced apoptosis

    • Li Liu
    • Renan Chen
    • Yingmin Liang

    Original Paper 26 January 2011 Pages: 243 - 247

    

38. Cardiac stunning as a manifestation of ATRA differentiation syndrome in acute promyelocytic leukemia

    • Gil C. De Santis
    • Maria Isabel A. Madeira
    • Eduardo M. Rego

    Case Report 26 January 2011 Pages: 248 - 250

    

39. High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China

    • Bin-Tao Huang
    • Qing-Chun Zeng
    • Hong-Qian Zhu

    Original Paper 22 January 2011 Pages: 251 - 259

    

40. Central nervous system relapse in CD56+, FLT3/ITD+ promyelocytic leukemia

    • N. Colovic
    • D. Tomin
    • Milica D. Colovic

    Case Report 05 February 2011 Pages: 260 - 262

    

41. Prognostic value of expression of EGFR and nm23 for locoregionally advanced nasopharyngeal carcinoma

    • Xiu Juan Cao
    • Jun Fang Hao
    • Jin Xu

    Orginal paper 08 January 2011 Pages: 263 - 271

    

42. Preliminary results of a phase III randomized study comparing chemotherapy neoadjuvantly or concurrently with radiotherapy for locoregionally advanced nasopharyngeal carcinoma

    • Tingting Xu
    • Chaosu Hu
    • Hongmei Ying

    Original Paper 30 January 2011 Pages: 272 - 278

    

43. Concomitant chemoradiotherapy using low-dose weekly gemcitabine versus low-dose weekly paclitaxel in locally advanced head and neck squamous cell carcinoma: a phase III study

    • Amal Ahmed-Fouad Halim
    • Hanan Ahmed Wahba
    • Ahmed Abo-Elyazeed

    Original Paper 30 January 2011 Pages: 279 - 284

    

44. Merged histological types of malignant thyroid tumor: experience and controversy

    • Liang Huang
    • Yan Zhang

    Original Paper 04 January 2011 Pages: 285 - 293

    

45. Cyclin A and cyclin B1 overexpression in differentiated thyroid carcinoma

    • Asli Nar
    • Ozlem Ozen
    • Beyhan Demirhan

    Original Paper 25 January 2011 Pages: 294 - 300

    

46. Response to temozolomide and bevacizumab in a patient with poorly differentiated neuroendocrine carcinoma

    • Daniel P. Lindholm
    • Barbro Eriksson
    • Dan Granberg

    Original Paper 30 December 2010 Pages: 301 - 303

    

47. Expression of PTTG1 and PTEN in endometrial carcinoma: correlation with tumorigenesis and progression

    • Zhen-Zhong Feng
    • Jia-Wei Chen
    • Zhao-Gen Cai

    Original paper 22 December 2010 Pages: 304 - 310

    

48. RNAi-mediated downregulation of NOB1 suppresses the growth and colony-formation ability of human ovarian cancer cells

    • Yang Lin
    • Shuai Peng
    • Manhua Cui

    Original Paper 02 February 2011 Pages: 311 - 317

    

49. The relevance and role of vascular endothelial growth factor C, matrix metalloproteinase-2 and E-cadherin in epithelial ovarian cancer

    • Ke-Jin Huang
    • Li-Hua Sui

    Original Paper 25 January 2011 Pages: 318 - 323

    

50. Vasculogenic mimicry–potential target for glioblastoma therapy: an in vitro and in vivo study

    • Yinsheng Chen
    • Zhitao Jing
    • Yunjie Wang

    Original Paper 14 December 2010 Pages: 324 - 331